Brief: Corbus Pharmaceuticals Data On Crb-601 Avβ8 Blocking Antibody Accepted For Presentation At The America Association For Cancer Research Annual Meeting
14/03/2023 23:00
March 14 (Reuters) - Corbus Pharmaceuticals Holdings Inc
CRBP.O :
* CORBUS PHARMACEUTICALS DATA ON CRB-601 AVΒ8 BLOCKING
ANTIBODY
ACCEPTED FOR PRESENTATION AT THE AMERICA ASSOCIATION FOR CANCER
RESEARCH ANNUAL MEETING
Source text for Eikon: ID:nPn1wvMHXa
Further company coverage: CRBP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Corbus Pharmaceuticals Holdings
See all newsU.S. STOCKS ON THE MOVE-PBF Energy, Crown Castle, Definium Therapeutics
U.S. STOCKS ON THE MOVE-PBF Energy, Crown Castle, Definium Therapeutics
U.S. STOCKS ON THE MOVE-AI stocks, energy companies, Johnson & Johnson
U.S. STOCKS ON THE MOVE-US energy stocks, Baldwin, Johnson & Johnson
Corbus gains on weight-loss data for obesity drug in early-stage study